ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Inflammation"

  • Abstract Number: 33 • 2014 ACR/ARHP Annual Meeting

    Stimulation of the Adenosine a2A receptor (A2AR) Regulates the Expression of Netrin1 and Their Receptors (Unc5b, DCC) and Inhibits Osteoclast Differentiation and Inflammatory Bone Destruction

    Aranzazu Mediero1, Bhama Ramkhelawon2, Miguel Perez-Aso3, Kathryn Moore2 and Bruce N. Cronstein4, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Leon H. Charney Division of Cardiology, Department of Medicine,, NYU School of Medicine, New York, NY, 3545 1st Ave., New York University, New York City, NY, 4NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose A variety of molecules mediate communication between osteoclasts and osteoblasts during bone remodeling. Netrin1 is a member of the family of axonal guidance proteins,…
  • Abstract Number: 2355 • 2014 ACR/ARHP Annual Meeting

    Apremilast, a Novel Phosphodiesterase 4 Inhibitor, and Methotrexate Independently Prevent Inflammation in Vivo and in Vitro

    Miguel Perez-Aso1, M. Carmen Montesinos2, Aranzazu Mediero3, Peter H. Schafer4 and Bruce N. Cronstein5, 1545 1st Ave., New York University, New York City, NY, 2Departament de Farmacologia, Facultat de Farmàcia,, Universitat de València, Valencia, Spain, 3Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 4Celgene Corporation, Celgene Corporation, Summit, NJ, 5NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Phosphodiesterase 4 (PDE4) inhibitors have clear immunoregulatory effects in laboratory studies, and the clinical application of this class of drug in the field of…
  • Abstract Number: 1510 • 2014 ACR/ARHP Annual Meeting

    Blockade of TLR5 Ligation Is a Novel Strategy for RA Therapy  

    Seung-jae Kim1, Zhenlong Chen1, Abdul Essani2, Michael Volin3, Suncica Volkov1, William Swedler4, Shiva Arami2, Nadera J. Sweiss5 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3Microbiology & Immunology, Midwestern University, Downers Grove, IL, 4Section of Rheumatology, University of Illinois at Chicago, Chicago, IL, 5internal medicine section of rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: TLR5 expression is highly elevated in RA and CIA lining and sublining macrophages and endothelial cells compared to non-arthritic controls. Additionally, expression of TLR5…
  • Abstract Number: 32 • 2014 ACR/ARHP Annual Meeting

    Regulation of Senescence and Inflammatory Mediators By N- and C-Terminal Parathyroid Hormone-Related Protein in Osteoarthritic Human Osteoblasts  

    Maria Isabel Guillén1, Julia Platas1, Sergio Portal-Nuñez2, Pedro Esbrit3 and M.J. Alcaraz4, 1Pharmacology, University of Valencia, Burjasot, Valencia, Spain, 2Metabolismo mineral y óseo, Fundación Jimenez Diaz, Madrid, Spain, 3Fundación Jimenez Diaz, Madrid, Spain, 4University of Valencia, Burjasot, Valencia, Spain

    Background/Purpose In osteoarthritis (OA), there is an abnormal remodeling process in subchondral bone associated with an altered osteoblast metabolism. Inflammatory mediators participate in bone remodeling…
  • Abstract Number: 2339 • 2014 ACR/ARHP Annual Meeting

    Detecting Inflammation in Vivo Using Activatable Fluorescence Contrast Agents in Inflammatory Arthritis

    Monica Guma1, Beatrix Bartok2, Viet Anh Nguyen Huu3, Mathieu L. Viger3, Jacques Lux3, Shivanjali Joshi-Barr3, Adah Almutairi3 and Gary S. Firestein4, 1Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 2Division of Rheumatology, allergy and immunology, University of California, San Diego, La Jolla, CA, 3UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences., University of California, San Diego, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA

     Background/Purpose: Current medical imaging technology detects structural rather than functional manifestations of disease.  Imaging agents designed to enhance signal based on molecular mechanisms might permit…
  • Abstract Number: 1468 • 2014 ACR/ARHP Annual Meeting

    Mechanism of Effectiveness of IL-6 Blockade for Reduction of SAA Production and Amyloid a Deposition in AA Amyloidosis Patients with RA

    Kazuyuki Yoshizaki, Osaka University, Osaka, Japan

    Background/Purpose AA amyloidosis is a serious complication of chronic inflammatory and infectious diseases resulting from the deposition of amyloid A protein. Serum amyloid A (SAA),…
  • Abstract Number: L17 • 2014 ACR/ARHP Annual Meeting

    Bariatric Surgery Improves Rheumatoid Arthritis Disease Activity, Reduces Inflammatory Markers, and Decreases Medication Usage

    Jeffrey A. Sparks1, Florencia Halperin2, Jonathan C. Karlson3, Elizabeth W. Karlson1 and Bonnie L. Bermas1, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Obesity causes a chronic inflammatory state. Increased body mass index (BMI) is associated with incident rheumatoid arthritis (RA) and may impact RA disease activity.…
  • Abstract Number: 2239 • 2014 ACR/ARHP Annual Meeting

    Efficacy of Ketoprofen Lysine Salt in Reducing Inflammation and Pain in Primary Osteoarthritis of the Hand: Preliminary Results of a Retrospective and Prospective Clinical Trial

    Maurizio Muratore1, Laura Quarta1, Antonella Grimaldi1, Daniela Costanza1, Luigi Lanata2, Michela Bagnasco2, Alessandra Monguzzi2 and Eugenio Quarta1, 1Department of Rheumatology, Hospital Galateo, San Cesario di Lecce, Italy, 2Medical Department, Dompé SpA, Milan, Italy

    Background/Purpose: Osteoarthritis (OA) is a common progressive joint disease and a leading cause of musculoskeletal pain and functional disability worldwide. Despite various interventional treatment approaches…
  • Abstract Number: 1291 • 2014 ACR/ARHP Annual Meeting

    Relationships Between Inflammation, Disease Severity and Synovial Fluid Calcium Crystals Detected By Scanning Electronic Microscopy in Early Osteoarthritis

    Paola Frallonardo1, Francesca Oliviero1, Luca Peruzzo2, Leonardo Tauro3, Anna Scanu1, Mariagrazia Lorenzin1, Augusta Ortolan1, Leonardo Punzi4 and Roberta Ramonda1, 1Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy, 2Institute for Geosciences and Earth Resources IGG-CNR, Padova, Italy, 3Department of Geosciences, University of Padova, Padova, Italy, 4Department of Medicine - DIMED, University of Padova, Padova, Italy

    Background/Purpose The presence of calcium crystals (CC) in synovial fluid (SF) of osteoarthritis (OA) is a well known and frequent feature (1). However, their role…
  • Abstract Number: 2225 • 2014 ACR/ARHP Annual Meeting

    Does Previous Corticosteroid Treatment Affect the Inflammatory Infiltrate Found in Polymyositis Muscle Biopsies?

    Mayara Mendes Pinhata1, Juliana Jesus do Nascimento1, Suely Kazue Nagahashi Marie2 and Samuel Katsuyuki Shinjo1, 1Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Neurology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: We conducted this study because there have been no studies evaluating the effect of the use of corticosteroids (CE) on the presence of inflammatory…
  • Abstract Number: 1204 • 2014 ACR/ARHP Annual Meeting

    Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFkB Signaling and Macrophage Migration

    Nicholas A. Young1, Michael Bruss2, Mark Gardner3, William Willis3, Xiaokui Mo3, Giancarlo Valiente3, Yu Cao4, Zhongfa Liu4, Lai-Chu Wu1 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Rheumatology and Immunology, The Ohio State University Wexner Medical Center, columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: The major obstacles to successful use of curcumin as an anti-inflammatory agent are its low solubility in water and rapid metabolism, which both translate…
  • Abstract Number: 2168 • 2014 ACR/ARHP Annual Meeting

    Extramedullary Myelopoiesis Drives Persistent Toll-like Receptor-Mediated Inflammation

    Lehn K. Weaver1 and Edward M. Behrens2, 1Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Pediatric Rheumatology, Childrens Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Many rheumatic diseases are driven by chronic, repeated activation of Toll-like receptors (TLR) causing the initiation and perpetuation of disease. However, TLR-activated innate immune…
  • Abstract Number: 1195 • 2014 ACR/ARHP Annual Meeting

    Activation of the nlrp3 Inflammasome By an Endogenous TLR2 Ligand in Rheumatoid Arthritis

    Mary Connolly, Trudy McGarry, Monika Biniecka, Douglas J. Veale and Ursula Fearon, Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland

    Background/Purpose: The inflammasome is a large multiprotein complex which plays a key role in innate immunity by mediating the production of pro-inflammatory cytokines interleukin-1β (IL-1β)…
  • Abstract Number: 1979 • 2014 ACR/ARHP Annual Meeting

    Pseudostarvation By AMPK Activator Therapy Is Associated with Reduced Disease Activity and Downregulation of Pro-Inflammatory Responses in Rheumatoid Arthritis (RA)

    Lorna Gallagher1, Ursula Fearon2, Douglas J. Veale3, David Kane1, Luke A. O'Neill4 and Ronan Mullan1, 1Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, 2Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 3Translational Rheumatology Research Group, St. Vincent's University Hospital, Dublin 4, Ireland, 4Inflammation Research, School of Biochemistry and Immunology, Dublin, Ireland

    Background/Purpose AMP-activated protein kinase (AMPK) is a highly conserved, regulator of cellular energy status. In inflammation, AMPK inactivation is associated with increased glucose consumption through…
  • Abstract Number: 1050 • 2014 ACR/ARHP Annual Meeting

    A Role for Purinergic Receptor Signalling in Basic Calcium Phosphate Crystal-Induced Inflammation

    Clare C. Cunningham1, Emma M. Corr1, Geraldine M. McCarthy2 and Aisling Dunne1, 1School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland, 2Medicine/Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland

    Background/Purpose: Basic calcium phosphate (BCP) crystals are uniquely associated with osteoarthritis (OA). They are found in the majority of affected joints and closely correlate with…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 67
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology